Your browser doesn't support javascript.
loading
Corrigendum to "Assessing the cost-utility of preferentially administering Heplisav-B vaccine to certain populations" [Vaccine 38(51) (2020) 8206-8215].
Rosenthal, Elizabeth M; Hall, Eric W; Rosenberg, Eli S; Harris, Aaron; Nelson, Noele P; Schillie, Sarah.
Affiliation
  • Rosenthal EM; Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, Rensselaer, NY, United States. Electronic address: emrosenthal@albany.edu.
  • Hall EW; Department of Epidemiology, Rollins School of Public Health, Emory University, Atlanta, GA, United States.
  • Rosenberg ES; Department of Epidemiology and Biostatistics, School of Public Health, University at Albany, Rensselaer, NY, United States.
  • Harris A; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Nelson NP; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
  • Schillie S; Division of Viral Hepatitis, Centers for Disease Control and Prevention, Atlanta, GA, United States.
Vaccine ; 39(36): 5231, 2021 Aug 23.
Article in En | MEDLINE | ID: mdl-34344554
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Países Bajos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Health_economic_evaluation Language: En Journal: Vaccine Year: 2021 Document type: Article Country of publication: Países Bajos